CD274 and neoplasm: However, in line with TCR-TMART-1 responding to tumor PD-L1 (Figure 4G), CD8+ T cells in PD-L1low patients had higher expression of STAT3 and CEBPB (Figure 7D), which are transcription factors for immune-suppressive cell subsets.